Found 111 matching trials
Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction PHASE2 This is a multicenter, double-blind, randomized, phase 2 trial to investiga...
Show More Location
The fourth hospital of Hebei Medical University
Learn More & Join Trial
A Study of Donafenib Plus S-1 in Treating Patients With Metastatic Pancreatic Cancer After Chemotherapy With Nab-paclitaxel Plus Gemcitabine Regimen PHASE2 This is a single arm, open label Phase II clinical trial to evaluate the ef...
Show More Learn More & Join Trial
Conversion Therapy of Sintilimab in Combination With Apatinib and Chemotherapy in Stage IV Gastric Cancer PHASE2 This is a single-arm, phase II study aiming to evaluate the feasibility and...
Show More Location
Department of Gastric Surgery, Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
Trial of Neoadjuvant Chemotherapy With S1 Plus Paclitaxel-albumin on Pancreatic Cancer PHASE2 The study is to evaluate the R0 resection rate of patients with unresectabl...
Show More Location
Zhejiang procincial people's hospital
Learn More & Join Trial
Surgical Conversion of Candonilimab (AK104) Plus Paclitaxel, S-1 and Apatinib for Unresectable Advanced G/GEJ Cancer PHASE2 This is a prospective, single-arm, open-label,single-center, phase II study...
Show More Location
Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
TOF Versus SOX in Metastatic Gastric Cancer PHASE2 This study was designed to compare the efficacy and safety of aclitaxel/oxa...
Show More Location
Multiple Locations
Learn More & Join Trial
Nonintervention Study on Peritoneal Metastasis of Stage IV Gastric Cancer N/A This is a non-interventional study,aim to observe the safety and efficiency...
Show More Location
Harbin Medical University Cancer Hospital
Learn More & Join Trial
Anlotinib Plus Nab-Paclitaxels and S-1 for Patients with Advanced Biliary Tract Cancer As Second-Line Treatment PHASE2 Biliary tract cancer (BTC) presents with a 5-year survival rate less than 5...
Show More Location
The First Affiliated Hospital of Sun Yat-sen University
Learn More & Join Trial
Iparomlimab/Tuvorlimab (QL1706) and Modified TPF Regimen for Induction Therapy in LANPC PHASE2 This is a prospective, open-label, multicenter, single-arm clinical study. ...
Show More Location
The First Affiliated Hospital of Xiamen University
Learn More & Join Trial
Neoadjuvant Nab-Paclitaxel and S-1 in Borderline Resectable Pancreatic Cancer PHASE2 This study was a single-arm multicenter prospective phase II clinical study...
Show More Location
Peking Union Medical College Hospital
Learn More & Join Trial